Literature DB >> 12801064

Effects of melanin upon susceptibility of Cryptococcus to antifungals.

Reiko Ikeda1, Takashi Sugita, Eric S Jacobson, Takako Shinoda.   

Abstract

Melanin is a recognized virulence factor in Cryptococcus neoformans; several pathogenetic mechanisms have been suggested. We studied melanin as an antifungal resistance factor. The growth of laccase-active strains of C. neoformans and C. albidus in L-DOPA resulted in the production of black pigment. The formal minimal inhibitory concentrations (MICs) of amphotericin B and fluconazole were not changed by melanization. However, when we examined those wells which contained inhibited cells, we found live cells only in wells containing melanized C. neoformans. In contrast, melanization did not protect C. albidus from killing by amphotericin B. In an amphotericin B time-kill study of C. neoformans, significantly more melanized cells than non-melanized survived for the first few hours. Fluorescence microscopy and flow cytometry analyses showed that fewer melanized cells were stained with the fluorescent dye MitoRed. Incubation of MitoRed (the model) or amphotericin B with melanin extracted from C. neoformans decreased the free concentrations of these substances. Fluconazole, in contrast, was not removed from solution by melanin. This suggests that neoformans cryptococcal melanin deposited amphotericin B in the cell wall binds, reducing its effective concentrations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801064     DOI: 10.1111/j.1348-0421.2003.tb03395.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  44 in total

Review 1.  Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds.

Authors:  Joshua D Nosanchuk; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2006-11       Impact factor: 5.191

2.  Melanization of Fusarium keratoplasticum (F. solani Species Complex) During Disseminated Fusariosis in a Patient with Acute Leukemia.

Authors:  Siri Chiewchanvit; Siriporn Chongkae; Pongsak Mahanupab; Joshua D Nosanchuk; Soraya Pornsuwan; Nongnuch Vanittanakom; Sirida Youngchim
Journal:  Mycopathologia       Date:  2017-06-14       Impact factor: 2.574

Review 3.  Immune response and immunotherapy to Cryptococcus infections.

Authors:  Qing Zhou; William J Murphy
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

4.  The effect of L-DOPA on Cryptococcus neoformans growth and gene expression.

Authors:  Helene C Eisenman; Siu-Kei Chow; Kenneth K Tsé; Erin E McClelland; Arturo Casadevall
Journal:  Virulence       Date:  2011-07-01       Impact factor: 5.882

5.  Dual infections with pigmented and albino strains of Cryptococcus neoformans in patients with or without human immunodeficiency virus infection in India.

Authors:  Piyali Mandal; Uma Banerjee; Arturo Casadevall; Joshua D Nosanchuk
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

6.  In Vitro Antifungal Susceptibility of Neoscytalidium dimidiatum Clinical Isolates from Malaysia.

Authors:  Jasper Elvin James; Jacinta Santhanam; Mei Chen Lee; Choon Xian Wong; Parameswari Sabaratnam; Hamidah Yusoff; Mohd Nizam Tzar; Mohd Fuat Abdul Razak
Journal:  Mycopathologia       Date:  2016-11-04       Impact factor: 2.574

7.  Effects of Pimenta pseudocaryophyllus (Gomes) L. R. Landrum, on melanized and non-melanized Cryptococcus neoformans.

Authors:  Orionalda de Fátima Lisboa Fernandes; Carolina Rodrigues Costa; Ruy de Souza Lino Junior; Marina Clare Vinaud; Lúcia Kioko Hasimoto E Souza; Joelma Abadia Marciano de Paula; Maria do Rosário Rodrigues Silva
Journal:  Mycopathologia       Date:  2012-08-30       Impact factor: 2.574

Review 8.  Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis.

Authors:  Kyung J Kwon-Chung; James A Fraser; Tamara L Doering; Zhou Wang; Guilhem Janbon; Alexander Idnurm; Yong-Sun Bahn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-01       Impact factor: 6.915

Review 9.  Physiological Differences in Cryptococcus neoformans Strains In Vitro versus In Vivo and Their Effects on Antifungal Susceptibility.

Authors:  Nina T Grossman; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

10.  A high-throughput screening assay for fungicidal compounds against Cryptococcus neoformans.

Authors:  Jennifer L A Rabjohns; Yoon-Dong Park; Jean Dehdashti; Christina Henderson; Adrian Zelazny; Steven J Metallo; Wei Zheng; Peter R Williamson
Journal:  J Biomol Screen       Date:  2013-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.